STAT3 and cancer: (2019) reported that fibroblast growth factor receptor (FGFR) inhibitor resistance in lung cancer is initially mediated by the cancer cell secretome activating STAT3 signalling; however, they also showed that this resistance could be enhanced via interactions with both fibroblasts and macrophages [74].